JCM
XPH icon

Janney Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Janney Capital Management’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,357
Closed -$653K – 244
2017
Q3 		$653K Sell
15,357
-1,123
-7% -$47.6K 0.03% 121
2017
Q2 		$709K Buy
+16,480
New +$695K 0.03% 107

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Janney Capital Management's XPH Position: Q4 2017 in Review

Janney Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2017, closing a stake of 15,357 shares — an estimated $653K sold.

Janney Capital Management first reported a position in XPH in Q2 2017 and held it in 2 quarters. The position peaked at $709K in Q2 2017. 85 funds tracked by Wall St. Rank hold XPH as of Q4 2017.

  • Janney Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
  • Janney Capital Management sold 15,357 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2017, an estimated $653K.
  • Janney Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2017 and held it in 2 quarters.
  • Janney Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $709K in Q2 2017.
  • 85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2017.

Based on Janney Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.